default author photo

John R. Bradley

University of Cambridge - Department of Medicine

Box 157

Hills Rd

Cambridge, CB2 0QQ

United Kingdom

SCHOLARLY PAPERS

3

DOWNLOADS

432

TOTAL CITATIONS

1

Scholarly Papers (3)

1.

Age-Related Heterogeneity in Neutralising Antibody Responses to SARS-CoV-2 Following BNT162b2 Vaccination

Number of pages: 18 Posted: 11 Feb 2021
University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University College London - Division of Infection and Immunity, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, NIHR Cambridge Biomedical Research Centre - NIHR BioResource, NIHR BioResource, NIHR Cambridge Biomedical Research Centre, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, Addenbrookes Hospital - Department of Clinical Biochemistry and Immunology, NIHR Cambridge Clinical Research Facility, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease and Cambridge Institute of Therapeutic Immunology & Infectious Disease
Downloads 253 (301,349)
Citation 1

Abstract:

Loading...

SARS-CoV-2; COVID-19; antibody; vaccine; neutralising antibodies

2.

B Cell Receptor Repertoire Kinetics after SARS-CoV-2 Infection and Vaccination

Number of pages: 51 Posted: 24 Aug 2021
University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Addenbrooke's Hospital - Division of Virology, University Hospital Basel - Immunobiology Laboratory, NHS Foundation Trust - Cambridge University Hospitals, University of Cambridge - Division of Virology, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease and University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease
Downloads 120 (596,393)

Abstract:

Loading...

3.

Early Immune Pathology and Persistent Dysregulation Characterise Severe COVID-19

Number of pages: 105 Posted: 29 Dec 2020
University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - MRC Biostatistics Unit, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, NIHR Cambridge Clinical Research Facility, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, University of Cambridge - Division of Virology, Cambridge Institute of Therapeutic Immunology & Infectious Disease, Addenbrooke's Hospital - Division of Virology, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, NIHR Cambridge Biomedical Research Centre - NIHR BioResource, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Murdoch University - The Centre for Computational and Systems Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - MRC Biostatistics Unit, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Hycult Biotech - R&D Department, University of Cambridge - Cambridge Institute for Medical Research, Independent, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, University Hospital Basel - Immunobiology Laboratory, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease and University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease
Downloads 59 (970,490)

Abstract:

Loading...